HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Visualizações
• 07/03/23
0
0
Embutir
administrator
Assinantes
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários